Sera Prognostics Reports $14K Revenue, $8.4M Net Loss in Q1; Announces 18% Workforce Reduction
summarizeSummary
SERA PROGNOSTICS, INC. reported Q1 2026 revenue of only $14K, a 63% year-over-year decline, and a net loss of $8.4 million, or $(0.17) per share. This report confirms the "significant losses" highlighted in the March 10-K, which also disclosed a $40 million ATM program to address capital needs. Crucially, the company announced an 18% workforce reduction in May 2026 and a strategic reallocation of resources from R&D towards commercialization and payer access. The extremely low revenue and substantial net loss, coupled with the significant workforce reduction and strategic pivot, signal ongoing financial distress and a critical need to conserve cash and accelerate commercialization. Traders will monitor the impact of these cost-cutting measures on the company's cash runway and the effectiveness of the new commercialization strategy in driving future revenue growth and securing payer reimbursement.
At the time of this announcement, SERA was trading at $1.72 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $70.9M. The 52-week trading range was $1.37 to $4.09. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Wiseek News.